Subscribe to RSS Feed
Medicines-Diabetes Treatment-Veropharm-Binnopharm-Micro Labs-Edas-Boiron-Pharmasoft-Gomeopharm-Hevert-Ozon-Serono-PharmSintez-Nycomed-NovoNordisk-Pfizer-Zentiva-Teva-Merck Sharp & Dohme-Dr.Reddy's-Sentiss-Belupo-Pharmstandart-Oxford-Actavis-Grindex-AlfaWassermann-Janssen-SUNpharma-Scan Biotech-Wockhardt-Alcon-Simpex-Aspera
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-Veropharm-Binnopharm-Micro Labs-Edas-Boiron-Pharmasoft-Gomeopharm-Hevert-Ozon-Serono-PharmSintez-Nycomed-NovoNordisk-Pfizer-Zentiva-Teva-Merck Sharp & Dohme-Dr.Reddy's-Sentiss-Belupo-Pharmstandart-Oxford-Actavis-Grindex-AlfaWassermann-Janssen-SUNpharma-Scan Biotech-Wockhardt-Alcon-Simpex-Aspera
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
Veropharm
Binnopharm
Micro Labs
Edas
Boiron
Pharmasoft
Gomeopharm
Hevert
Ozon
Serono
PharmSintez
Nycomed
NovoNordisk
Pfizer
Zentiva
Teva
Merck Sharp & Dohme
Dr.Reddy's
Sentiss
Belupo
Pharmstandart
Oxford
Actavis
Grindex
AlfaWassermann
Janssen
SUNpharma
Scan Biotech
Wockhardt
Alcon
Simpex
Aspera
- The purpose of the medication
- Manufacturer
